Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Yesterday, Associate Professor Mathilda Mommersteeg appeared on three BBC radio programmes to discuss her British Heart Foundation funded research into the Mexican cavefish's remarkable heart and its potential to change the lives of people with damaged hearts.

 

BBC Radio Oxford, Howard Bentham - starting soon after 4.20pm (23 minutes in).

 

BBC Radio 4, Today - starting at 8.40pm (2 hours 40 minutes in).

 

BBC World Service, Newsday - closing the show at 49 minutes and 30 seconds in.

Similar stories

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Louisa Zolkiewski awarded the Bruce Cattanach Prize 2022

Congratulations are in order for Louisa Zolkiewski, who completed her DPhil studies this year, on being awarded the 2022 Bruce Cattanach Prize by the Genetics Society for her DPhil thesis.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.